Advertisement

FOXO

FOXO Technologies Inc.

Healthcare · USD

Set alert

Price alert · FOXO

All alert types
0.10 USD +0.01 +11.11%
As of Oct 30, 2026 Extended hours 0.10 +2.30%
Bid
0.09 × 39,500
Ask
0.09 × 5,000
0.0666 Day range 0.10
0.03 52-week range 4.50
YTD
-66.67%
1 year
-95.83%
Open
0.0666
Prev close
0.09
Mkt cap
99.49K
Vol
16.25K
Avg vol
5.08K
EPS
1,410.07
P/E
0.00
Div yield
0.00%
More statistics
Low
0.0666
High
0.10
Forward P/E
0.00
Beta
2.06
Short ratio
0.24
Inst. own
2.26%
Dividend
0.00
Ex-div date
50-d avg
0.39948
200-d avg
0.28671
1y target
0.00

5D chart

Chart tools
Interval
FOXO five-day price chart0.070.070.080.090.10Oct 26Oct 27Oct 30

Key statistics

Market cap
4.81M
Enterprise value
19.47M
Trailing P/E
5.51
Forward P/E
0.00
PEG ratio
0.00
Price / sales
31.06
Price / book
0.00
EPS (TTM)
0.05
Beta
2.06
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
155.00K
Revenue growth
133.30%
Free cash flow
1.54M
Total cash
33.00K
Total debt
10.14M
Return on equity
0.00%
Shares outstanding
17.48M
Short % of float
0.44%
50-day average
0.39948
200-day average
0.28671

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
FOXO Revenue — quarterly 3.17M
2021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 2025
FOXO Net income — quarterly -616.46K
2021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 2025
FOXO EPS — quarterly -0.74
2021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 2025

About FOXO Technologies Inc.

FOXO Technologies Inc. develops epigenetic biomarkers technology solutions in the United States. The company applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and Bioinformatics services that provides data solutions using AI and machine learning for data analysis and processing, and quality checking for academia, healthcare, government, and pharmaceutical research customers. FOXO Technologies Inc. was founded in 2020 and is based in Minneapolis, Minnesota.

Sector
Healthcare
Industry
Health Information Services
Country
United States

News

Your note

Sign in to keep a note on FOXO — it syncs with the Stock Master app.

Insider holders

FOXO insider holders
InsiderRelationLatest transactionDateShares held
DOWLING VINCENT J JRBeneficial Owner of more than 10% of a Class of SecuritySaleJul 13, 20230
KR8 AI INCBeneficial Owner of more than 10% of a Class of SecuritySaleJul 21, 20240
WARD MARTIN CHRISTOPHERChief Financial OfficerSaleJul 21, 20240
WHITE MARK BRIANChief Executive OfficerSaleJul 21, 20240

Institution ownership

FOXO institution ownership
Holder% heldSharesValueReported
Susquehanna International Group, LLP0.59%103,94528.64KSep 29, 2024
Geode Capital Management, LLC0.24%42,46111.70KSep 29, 2024
Virtu Financial LLC0.22%38,97610.74KSep 29, 2024
Corbin Capital Partners, LP0.16%27,4807.57KSep 29, 2024
Xtx Topco Ltd0.15%25,9457.15KSep 29, 2024
Vanguard Group Inc0.14%24,2386.68KSep 29, 2024

Fund ownership

FOXO fund ownership
Holder% heldSharesValueReported
Fidelity Extended Market Index Fund0.20%35,2939.72KOct 30, 2024
Vanguard Extended Market Index Fund0.14%24,2386.68KSep 29, 2024
Fidelity Total Market Index Fund0.03%4,7701.31KOct 30, 2024
Fidelity Series Total Market Index Fund0.01%1,734477Oct 30, 2024
Advertisement